Cybin - Stock Price History | CYBN

Historical daily share price chart and data for Cybin since 2021 adjusted for splits. The latest closing stock price for Cybin as of October 15, 2021 is 1.97.
  • The all-time high Cybin stock closing price was 2.80 on August 31, 2021.
  • The Cybin 52-week high stock price is 3.22, which is 63.5% above the current share price.
  • The Cybin 52-week low stock price is 1.68, which is 14.7% below the current share price.
  • The average Cybin stock price for the last 52 weeks is 2.26.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Cybin Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.324B $0.001B
Cybin Inc. is a biotechnology company. It is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. Cybin Inc. is based in Toronto, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $128.216B 8.54
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.812B 20.00
Biohaven Pharmaceutical Holding (BHVN) United States $8.815B 0.00
Emergent Biosolutions (EBS) United States $2.763B 6.66
Arcus Biosciences (RCUS) United States $2.321B 0.00
Myovant Sciences (MYOV) United Kingdom $1.993B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.769B 0.00
Zymeworks (ZYME) Canada $1.152B 0.00
Ambrx Biopharma (AMAM) United States $0.431B 0.00
SQZ Biotechnologies (SQZ) United States $0.346B 0.00
Enzo Biochem (ENZ) United States $0.188B 18.43